1 – 12 of 12
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
- 2022
-
Mark
Cardiovascular effects of intrauterine exposure to maternal HIV and antiretroviral therapy in Ethiopian infants followed from fetal life
(
- Contribution to journal › Article
- 2021
-
Mark
Interferon-g-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV
(
- Contribution to journal › Article
-
Mark
Low-level HIV viremia during antiretroviral therapy
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Pregnancy in women diagnosed with hiv on antiretroviral therapy in ethiopia : A retrospective cohort study
(
- Contribution to journal › Article
-
Mark
The HIV care continuum and HIV-1 drug resistance among female sex workers : a key population in Guinea-Bissau
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of the Viral Load Testing Criteria – an algorithm for targeted viral load testing in HIV-positive adults receiving antiretroviral therapy
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
(
- Contribution to journal › Article
- 2016
-
Mark
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
(
- Contribution to journal › Article
- 2013
-
Mark
Platelet count kinetics following Interruption of antiretroviral treatment: Results from the SMART study.
(
- Contribution to journal › Article
- 2008
-
Mark
Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003-2005
(
- Contribution to journal › Article
- 2007
-
Mark
Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004
(
- Contribution to journal › Article